This is a Validated Antibody Database (VAD) review about human TSC22D1, based on 1 published articles (read how Labome selects the articles), using TSC22D1 antibody in all methods. It is aimed to help Labome visitors find the most suited TSC22D1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TSC22D1 synonym: Ptg-2; TGFB1I4; TSC22; TSC22 domain family protein 1; TGFB-stimulated clone 22 homolog; TGFbeta-stimulated clone 22; cerebral protein 2; regulatory protein TSC-22; transcriptional regulator TSC-22; transforming growth factor beta-1-induced transcript 4 protein; transforming growth factor beta-stimulated protein TSC-22

Santa Cruz Biotechnology
mouse monoclonal (R5-6)
  • immunoprecipitation; human; fig 1b
  • immunohistochemistry; human; fig 2a
  • western blot; human; fig 1b
Santa Cruz Biotechnology TSC22D1 antibody (Santa Cruz, sc-101195) was used in immunoprecipitation on human samples (fig 1b), in immunohistochemistry on human samples (fig 2a) and in western blot on human samples (fig 1b). Oncotarget (2017) ncbi
Articles Reviewed
  1. Cho M, Lee J, Shin M, Kim H, Choi Y, Rho S, et al. TSC-22 inhibits CSF-1R function and induces apoptosis in cervical cancer. Oncotarget. 2017;8:97990-98003 pubmed publisher